|
|
||||||||


* Laboratory of Molecular Immunoregulation and
Basic Research Program, SAIC-Frederick, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702; and
Pathology Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892
Alzheimers disease (AD) is characterized by overproduction of
amyloid peptides in the brain with progressive loss of neuronal cells. The 42-aa form of the
amyloid peptide (A
42) is implied as a major causative factor, because it is toxic to neurons and elicits inflammatory responses in the brain by activating microglial cells. Despite the overproduction of A
42, AD brain tissue also generates protective factor(s) that may antagonize the neurodestructive effect of A
42. Humanin is a gene cloned from an apparently normal region of an AD brain and encodes a 24-aa peptide. Both secreted and synthetic Humanin peptides protect neuronal cells from damage by A
42, and the effect of Humanin may involve putative cellular receptor(s). To elucidate the molecular identity of such receptor(s), we examined the activity of synthetic Humanin on various cells and found that Humanin induced chemotaxis of mononuclear phagocytes by using a human G protein-coupled formylpeptide receptor-like-1 (FPRL1) and its murine counterpart FPR2. Coincidentally, FPRL1 and FPR2 are also functional receptors used by A
42 to chemoattract and activate phagocytic cells. Humanin reduced the aggregation and fibrillary formation by suppressing the effect of A
42 on mononuclear phagocytes. In neuroblast cells, Humanin and A
42 both activated FPRL1; however, only A
42 caused apoptotic death of the cells, and its cytopathic effect was blocked by Humanin. We conclude that Humanin shares human FPRL1 and mouse FPR2 with A
42 and suggest that Humanin may exert its neuroprotective effects by competitively inhibiting the access of FPRL1 to A
42.
Related articles in The JI:
This article has been cited by other articles:
![]() |
Y. Hashimoto, M. Kurita, S. Aiso, I. Nishimoto, and M. Matsuoka Humanin Inhibits Neuronal Cell Death by Interacting with a Cytokine Receptor Complex or Complexes Involving CNTF Receptor {alpha}/WSX-1/gp130 Mol. Biol. Cell, June 15, 2009; 20(12): 2864 - 2873. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Ye, F. Boulay, J. M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C. N. Serhan, and P. M. Murphy International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family Pharmacol. Rev., June 1, 2009; 61(2): 119 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Devosse, A. Guillabert, N. D'Haene, A. Berton, P. De Nadai, S. Noel, M. Brait, J.-D. Franssen, S. Sozzani, I. Salmon, et al. Formyl Peptide Receptor-Like 2 Is Expressed and Functional in Plasmacytoid Dendritic Cells, Tissue-Specific Macrophage Subpopulations, and Eosinophils J. Immunol., April 15, 2009; 182(8): 4974 - 4984. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. N. E. Gavins, J. Dalli, R. J. Flower, D. N. Granger, and M. Perretti Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation FASEB J, June 1, 2007; 21(8): 1751 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Miao, B. A. Premack, Z. Wei, Y. Wang, C. Gerard, H. Showell, M. Howard, T. J. Schall, and R. Berahovich Proinflammatory Proteases Liberate a Discrete High-Affinity Functional FPRL1 (CCR12) Ligand from CCL23 J. Immunol., June 1, 2007; 178(11): 7395 - 7404. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Gao, A. Guillabert, J. Hu, Y. Le, E. Urizar, E. Seligman, K. J. Fang, X. Yuan, V. Imbault, D. Communi, et al. F2L, a Peptide Derived from Heme-Binding Protein, Chemoattracts Mouse Neutrophils by Specifically Activating Fpr2, the Low-Affinity N-Formylpeptide Receptor J. Immunol., February 1, 2007; 178(3): 1450 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chen, P. Iribarren, J. Huang, L. Zhang, W. Gong, E. H. Cho, S. Lockett, N. M. Dunlop, and J. M. Wang Induction of the Formyl Peptide Receptor 2 in Microglia by IFN-{gamma} and Synergy with CD40 Ligand J. Immunol., February 1, 2007; 178(3): 1759 - 1766. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Prat, J. Bestebroer, C. J. C. de Haas, J. A. G. van Strijp, and K. P. M. van Kessel A New Staphylococcal Anti-Inflammatory Protein That Antagonizes the Formyl Peptide Receptor-Like 1 J. Immunol., December 1, 2006; 177(11): 8017 - 8026. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chen, P. Iribarren, J. Hu, J. Chen, W. Gong, E. H. Cho, S. Lockett, N. M. Dunlop, and J. M. Wang Activation of Toll-like Receptor 2 on Microglia Promotes Cell Uptake of Alzheimer Disease-associated Amyloid beta Peptide J. Biol. Chem., February 10, 2006; 281(6): 3651 - 3659. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Iribarren, K. Chen, J. Hu, X. Zhang, W. Gong, and J. M. Wang IL-4 Inhibits the Expression of Mouse Formyl Peptide Receptor 2, a Receptor for Amyloid {beta}1-42, in TNF-{alpha}-Activated Microglia J. Immunol., November 1, 2005; 175(9): 6100 - 6106. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Migeotte, E. Riboldi, J.-D. Franssen, F. Gregoire, C. Loison, V. Wittamer, M. Detheux, P. Robberecht, S. Costagliola, G. Vassart, et al. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2 J. Exp. Med., January 3, 2005; 201(1): 83 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nanamori, X. Cheng, J. Mei, H. Sang, Y. Xuan, C. Zhou, M.-W. Wang, and R. D. Ye A Novel Nonpeptide Ligand for Formyl Peptide Receptor-Like 1 Mol. Pharmacol., November 1, 2004; 66(5): 1213 - 1222. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |